SCHEMBL22011540

SCHEMBL22011540

c1ccc2c(c1)oc1ccc3c(c12)c1c2ccccc2oc1c1c2ccccc2n(-c2ccc4c5ccccc5c5ccccc5c4c2)c31

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.32
LMNA P02545 1/20 0.32
PPARG P37231 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NR2E3 Q9Y5X4 1/20 0.32
NCOR2 Q9Y618 1/20 0.32
CHRNA7 P36544 1/20 0.31
KCNH2 Q12809 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
AHR P35869 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22011373 0.91 ALDH1A1 (0.32) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL17405529 0.91 RXFP1 (0.34) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL22011538 0.90 KDM4E (0.39) ALDH1A1LMNAPPARGRXFP1NR2E3
SCHEMBL22011531 0.89 KDM4E (0.40) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL16275614 0.89 RXFP1 (0.37) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL22011543 0.89 KDM4E (0.40) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL17405525 0.87 ALDH1A1 (0.40) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL17405651 0.87 RXFP1 (0.34) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL19986058 0.87 RXFP1 (0.34) ALDH1A1LMNAPPARGNPSR1RXFP1
SCHEMBL17405730 0.87 RXFP1 (0.36) ALDH1A1LMNAPPARGNPSR1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
US-12035625-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2024-07-09 US disclosed
EP-3880682-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-06-14 EP disclosed
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-01-06 US disclosed
WO-2020099307-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220006030-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES ZYX, RER1, AOC2 ALDH1A1 1119/4885LMNA 1050/4885PPARG 3061/4885
US-12035625-B2 Materials for organic electroluminescent devices ZYX, RER1, AOC2 ALDH1A1 1119/4885LMNA 1050/4885PPARG 3061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.